spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1'-oxo-, trans-
MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.